{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:13:08Z","timestamp":1761012788740,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2116,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.seizure.2007.04.007","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T07:18:54Z","timestamp":1180682334000},"page":"593-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Topiramate in add-on therapy: Results from an open-label, observational study"],"prefix":"10.1016","volume":"16","author":[{"given":"K.","family":"Krakow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Lengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Rettig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schreiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schauble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 9","key":"10.1016\/j.seizure.2007.04.007_bib1","first-page":"S21","article-title":"Monotherapy trials of new antiepileptic drugs","volume":"38","author":"Beydoun","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.04.007_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine\/Carbamazepine Monotherapy Trial Group","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2007.04.007_bib3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJM200002033420503","article-title":"Early identification of refractory epilepsy","volume":"342","author":"Kwan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2007.04.007_bib4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0028-3908(01)00171-X","article-title":"Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance","volume":"42","author":"Herrero","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2007.04.007_bib5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2165\/00023210-200317130-00007","article-title":"Topiramate: as monotherapy in newly diagnosed epilepsy","volume":"17","author":"Waugh","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.seizure.2007.04.007_bib6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00003088-200443120-00001","article-title":"Pharmacokinetic interactions of topiramate","volume":"43","author":"Bialer","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl 1","key":"10.1016\/j.seizure.2007.04.007_bib7","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1111\/j.1528-1157.2000.tb02175.x","article-title":"Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults","volume":"41","author":"Reife","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.04.007_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1528-1157.1999.tb05561.x","article-title":"New antiepileptic drugs: comparison of key clinical trials","volume":"40","author":"Cramer","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2007.04.007_bib9","doi-asserted-by":"crossref","unstructured":"Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30:389\u201399.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"10.1016\/j.seizure.2007.04.007_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1034\/j.1600-0404.2002.02071.x","article-title":"Low-dose topiramate in adults with treatment-resistant partial-onset seizures","volume":"106","author":"Guberman","year":"2002","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2007.04.007_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1600-0404.2003.00113.x","article-title":"A pooled analysis of adjunctive topiramate in refractory partial epilepsy","volume":"108","author":"Peeters","year":"2003","journal-title":"Acta Neurol Scand"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107000969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131107000969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:35:54Z","timestamp":1761010554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131107000969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1059131107000969"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2007.04.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate in add-on therapy: Results from an open-label, observational study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2007.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}